Authors:
Greer, S
Alvarez, M
Mas, M
Wozniak, C
Arnold, D
Knapinska, A
Norris, C
Burk, R
Aller, A
Dauphinee, M
Citation: S. Greer et al., Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer,effectively controls five advanced human tumors in nude mice, INT J RAD O, 51(3), 2001, pp. 791-806
Authors:
Minkoff, H
Ahdieh, L
Massad, LS
Anastos, K
Watts, DH
Melnick, S
Muderspach, L
Burk, R
Palefsky, J
Citation: H. Minkoff et al., The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women, AIDS, 15(16), 2001, pp. 2157-2164
Authors:
Burk, R
Weinreb, R
Sample, P
Johnson, C
Cioffi, G
Citation: R. Burk et al., Questions and answers following session III. Clinical detection and measurement of optic nerve damage, SURV OPHTHA, 45, 2001, pp. S332-S334
Authors:
Ahdieh, L
Klein, RS
Burk, R
Cu-Uvin, S
Schuman, P
Duerr, A
Safaeian, M
Astemborski, J
Daniel, R
Shah, K
Citation: L. Ahdieh et al., Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women, J INFEC DIS, 184(6), 2001, pp. 682-690
Authors:
Duerr, A
Kieke, B
Warren, D
Shah, K
Burk, R
Peipert, JF
Schuman, P
Klein, RS
Citation: A. Duerr et al., Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus, AM J OBST G, 184(4), 2001, pp. 584-590
Authors:
Palefsky, JM
Minkoff, H
Kalish, LA
Levine, A
Sacks, HS
Garcia, P
Young, M
Melnick, S
Miotti, P
Burk, R
Citation: Jm. Palefsky et al., Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women, J NAT CANC, 91(3), 1999, pp. 226-236
Authors:
Minkoff, HL
Eisenberger-Matityahu, D
Feldman, J
Burk, R
Clarke, L
Citation: Hl. Minkoff et al., Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus, AM J OBST G, 180(4), 1999, pp. 824-834
Authors:
Galbiati, F
Volonte, D
Engelman, JA
Watanabe, G
Burk, R
Pestell, RG
Lisanti, MP
Citation: F. Galbiati et al., Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade, EMBO J, 17(22), 1998, pp. 6633-6648